The BRAINFOOD Trial to Prevent Recurrent Hepatic Encephalopathy.

Inclusion Criteria: * Diagnosis of cirrhosis will be based upon: 1. liver biopsy, OR 2. history of cirrhosis complication: ascites, variceal bleeding, hepatic encephalopathy, OR 3. 2 of the following 4 criteria: 1. Ultrasound, Computed tomography (CT), or Magnetic resonance imaging (MRI) findings of cirrhosis (cirrhotic appearing liver, splenomegaly, varices, ascites) 2. Fibroscan liver stiffness score \>13 kilopascals (kPa) 3. Laboratory testing: aspartate aminotransferase/platelet ratio index (APRI) \>2.0 4. CT, MRI or esophagogastroduodenoscopy (EGD) showing presence of esophageal varices * Patients with history of \> grade 2 HE within 180 days of enrollment based on review of clinical documentation verifying the event. If a description of HE symptoms is provided in clinical documentation, but it is unclear if it meets Grade 2 criteria, the principal investigator will assess the clinical documentation and provide an HE grade. Exclusion Criteria: * Non-English speaking * Model for End-Stage Liver Disease (MELD) Score \> 20 * Pregnancy (self-reported) * Unable or unwilling to provide consent * History of liver transplant * Current or planned admission to a nursing facility * Serum creatinine \> 2.0 milligrams per deciliter (mg/dL) (with the exception that we will include patients with a serum creatinine \> 2.0 mg/dL if they are receiving hemodialysis) * Disorientation at the time of enrollment * Barcelona-Clinic Liver Cancer (BCLC) Stage D Hepatocellular Carcinoma with Child-Turcotte-Pugh (CTP) Class C * History of eating disorder